SCHEMBL3862559

SCHEMBL3862559

O=C(NCCCN1CCOCC1)Nc1cccc(Cn2nc(-c3ccccc3)ccc2=O)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MET P08581 3/20 0.64
▸ TSHR P16473 3/20 0.53
▸ USP2 O75604 1/20 0.53
▸ MAPT P10636 2/20 0.52
▸ ALDH1A1 P00352 1/20 0.52
▸ L3MBTL1 Q9Y468 1/20 0.52
▸ TP53 P04637 1/20 0.52
▸ MEN1 O00255 1/20 0.52
▸ CYP3A4 P08684 1/20 0.52
▸ GAA P10253 1/20 0.52
▸ CYP2D6 P10635 1/20 0.52
▸ ALOX15 P16050 1/20 0.52
▸ KMT2A Q03164 1/20 0.52
▸ TRPV4 Q9HBA0 1/20 0.51
▸ SMN1; SMN2 Q16637 2/20 0.51
▸ TACR2 P21452 2/20 0.51
▸ PDGFRB P09619 1/20 0.47
▸ FLT1 P17948 1/20 0.47
▸ KDR P35968 1/20 0.47
▸ PRMT3 O60678 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4122227 0.93 MET (0.68) METTSHRUSP2MAPTCYP3A4
SCHEMBL2469466 0.91 MET (0.78) METTSHRUSP2MAPTCYP3A4
Hydrochloric Acid SCHEMBL2673443 0.90 MET (0.76) METTSHRUSP2MAPTCYP3A4
SCHEMBL2467968 0.90 MET (0.64) METTSHRUSP2MAPTSMN1; SMN2
SCHEMBL2471211 0.86 MET (0.75) MET
SCHEMBL2467416 0.85 MET (0.61) METSMN1; SMN2
SCHEMBL2471041 0.83 MET (0.66) METTSHRUSP2MAPTALDH1A1
SCHEMBL4125120 0.83 MET (0.66) MET
SCHEMBL2469596 0.82 MET (0.65) METTSHRUSP2TP53ALOX15
SCHEMBL2469585 0.82 MET (0.54) METTSHRUSP2MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8314087-B2 Nitrogen-containing heterocyclyl ketones and methods of use AMGEN INC. (US) 2012-11-20 — — US disclosed
US-8314087-B2 Nitrogen-containing heterocyclyl ketones and methods of use AMGEN INC. (US) 2012-11-20 — — US disclosed
US-8314087-B2 Nitrogen-containing heterocyclyl ketones and methods of use AMGEN INC. (US) 2012-11-20 — — US disclosed
EP-2114898-A2 NITROGEN-CONTAINING HETEROCYCLYL KETONES AND THEIR USE AS C-MET INHIBITORS Amgen Inc. (US) 2009-11-11 — — EP disclosed
US-20080280917-A1 Nitrogen-Containing heterocyclyl ketones and methods of use AMGEN INC. (US) 2008-11-13 — — US disclosed
US-20080280917-A1 Nitrogen-Containing heterocyclyl ketones and methods of use AMGEN INC. (US) 2008-11-13 — — US disclosed
US-20080280917-A1 Nitrogen-Containing heterocyclyl ketones and methods of use AMGEN INC. (US) 2008-11-13 — — US disclosed
WO-2008103277-A2 NITROGEN-CONTAINING HETEROCYCLYL KETONES AND THEIR USE AS C-MET INHIBITORS AMGEN INC. (US) 2008-08-28 — — WO disclosed
WO-2008103277-A2 NITROGEN-CONTAINING HETEROCYCLYL KETONES AND THEIR USE AS C-MET INHIBITORS AMGEN INC. (US) 2008-08-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080280917-A1 Nitrogen-Containing heterocyclyl ketones and methods of use HGF, HGFAC, MET MET 3/4885TSHR 3180/4885USP2 4084/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback